{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:15:45Z","timestamp":1791803745721,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T00:00:00Z","timestamp":1751932800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.neurol.2025.06.007","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T00:08:18Z","timestamp":1752624498000},"page":"667-673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Description of peripheral nervous system involvement in wild-type transthyretin amyloidosis: A clinical and electrophysiological study"],"prefix":"10.1016","volume":"181","author":[{"given":"R.","family":"Barriol","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6828-3877","authenticated-orcid":false,"given":"B.","family":"Lemarchant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Cassim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-B.","family":"Davion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Defebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1194-5590","authenticated-orcid":false,"given":"J.-B.","family":"Gibier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Lamblin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6654-8090","authenticated-orcid":false,"given":"C.","family":"Tard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.neurol.2025.06.007_bib0140","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s40120-020-00210-7","article-title":"Transthyretin amyloidosis: update on the clinical spectrum, pathogenesis, and disease-modifying therapies","volume":"9","author":"Koike","year":"2020","journal-title":"Neurol Ther"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.007_bib0145","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","article-title":"Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments","volume":"86","author":"Sekijima","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.007_bib0150","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.neurol.2021.02.392","article-title":"Electro-clinical presentation of hereditary transthyretin related amyloidosis when presenting as a polyneuropathy of unknown origin in northern France","volume":"177","author":"Davion","year":"2021","journal-title":"Rev Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.007_bib0155","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/ane.13035","article-title":"Hereditary transthyretin-related amyloidosis","volume":"139","author":"Finsterer","year":"2019","journal-title":"Acta neurol Scand"},{"issue":"7","key":"10.1016\/j.neurol.2025.06.007_bib0160","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1212\/01.wnl.0000267338.45673.f4","article-title":"Diagnostic pitfalls in sporadic transthyretin familial amyloid polyneuropathy (TTR-FAP)","volume":"69","author":"Plant\u00e9-Bordeneuve","year":"2007","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.007_bib0165","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1111\/ene.13845","article-title":"Upper limb onset of hereditary transthyretin amyloidosis is common in non-endemic areas","volume":"26","author":"Th\u00e9audin","year":"2019","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.007_bib0170","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.neurol.2022.11.011","article-title":"How should we diagnose CNS involvement of transthyretin amyloidosis?","volume":"179","author":"Hamimed","year":"2023","journal-title":"Rev Neurol (Paris)"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.007_bib0175","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/0002-9343(83)90443-6","article-title":"Frequency and distribution of senile cardiovascular amyloid. A clinicopathologic correlation","volume":"75","author":"Cornwell","year":"1983","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.007_bib0180","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/13506129.2021.1976751","article-title":"Clinical and apparative investigation of large and small nerve fiber impairment in mixed cohort of ATTR-amyloidosis: impact on patient management and new insights in wild-type","volume":"29","author":"Papagianni","year":"2022","journal-title":"Amyloid"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.007_bib0185","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10072-022-06459-0","article-title":"Peripheral nerve involvement in wild-type transthyretin amyloidosis","volume":"44","author":"Campagnolo","year":"2023","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1016\/j.neurol.2025.06.007_bib0190","first-page":"2","article-title":"Wild-type transthyretin amyloid cardiomyopathy complicated by spinal canal stenosis, carpal tunnel syndrome, and rotator cuff tears: a case report","volume":"4","author":"Takashio","year":"2020","journal-title":"Eur Heart J Case Rep"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.007_bib0195","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.humpath.2010.11.017","article-title":"Wild-type transthyretin-derived amyloidosis in various ligaments and tendons","volume":"42","author":"Sueyoshi","year":"2011","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.007_bib0200","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s40119-021-00222-w","article-title":"Multidisciplinary approaches for transthyretin amyloidosis","volume":"10","author":"Koike","year":"2021","journal-title":"Cardiol Ther"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.007_bib0205","doi-asserted-by":"crossref","first-page":"e006075","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.neurol.2025.06.007_bib0210","doi-asserted-by":"crossref","first-page":"116424","DOI":"10.1016\/j.jns.2019.116424","article-title":"Development of measures of polyneuropathy impairment in hATTR amyloidosis: from NIS to mNIS+7","volume":"405","author":"Dyck","year":"2019","journal-title":"J Neurol Sci"},{"issue":"4","key":"10.1016\/j.neurol.2025.06.007_bib0215","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/jns.12513","article-title":"The diagnostic accuracy of the small fiber neuropathy symptoms inventory questionnaire (SFN-SIQ) for identifying pure small fiber neuropathy","volume":"27","author":"Galosi","year":"2002","journal-title":"J Peripher Nerv Syst"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.007_bib0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1212\/01.WNL.0000149522.32823.EA","article-title":"Distal symmetric polyneuropathy: a definition for clinical research: report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"64","author":"England","year":"2005","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.neurol.2025.06.007_bib0225","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1089\/dia.2013.0129","article-title":"Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction","volume":"15","author":"Casellini","year":"2013","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"10.1016\/j.neurol.2025.06.007_bib0230","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/ene.15176","article-title":"Changes in nerve conduction studies predate clinical symptoms onset in early onset Val30Met hereditary ATTR amyloidosis","volume":"29","author":"Castro","year":"2022","journal-title":"Eur J Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2025.06.007_bib0235","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.neurol.2019.11.007","article-title":"Neuropathy of the elderly","volume":"176","author":"Bouche","year":"2020","journal-title":"Rev Neurol (Paris)"},{"issue":"16","key":"10.1016\/j.neurol.2025.06.007_bib0240","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1212\/WNL.0000000000001492","article-title":"Impairments and comorbidities of polyneuropathy revealed by population-based analyses","volume":"84","author":"Hoffman","year":"2015","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2025.06.007_bib0245","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1017\/cjn.2020.271","article-title":"Utility of neuropathy screening for wild-type transthyretin amyloidosis patients","volume":"48","author":"Russell","year":"2021","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"10.1016\/j.neurol.2025.06.007_bib0250","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1080\/13506129.2024.2319133","article-title":"Gait abnormalities in older adults with transthyretin cardiac amyloidosis","volume":"31","author":"Petros","year":"2024","journal-title":"Amyloid"},{"issue":"8","key":"10.1016\/j.neurol.2025.06.007_bib0255","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1212\/WNL.0b013e3182661eb1","article-title":"Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial","volume":"79","author":"Coelho","year":"2012","journal-title":"Neurology"},{"issue":"24","key":"10.1016\/j.neurol.2025.06.007_bib0260","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.neurol.2025.06.007_bib0265","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.neurol.2025.06.007_bib0270","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1474-4422(20)30368-9","article-title":"Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study","volume":"20","author":"Adams","year":"2021","journal-title":"Lancet Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725005478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,23]],"date-time":"2025-08-23T12:58:05Z","timestamp":1755953885000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725005478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":27,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S0035378725005478"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.06.007","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Description of peripheral nervous system involvement in wild-type transthyretin amyloidosis: A clinical and electrophysiological study","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}